Showing results (131-140 of 336) with videos related to

Sort By:
Pageof 34
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 25, 2015
Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced ThrombocytopeniaBrianne M Ritchie, Jean M Connors, Katelyn W Sylvester
Postgraduate Medicine|July 13, 2021
A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatmentElliott J Brea, Bruce C Tiu, Jean M Connors
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
Improving anticoagulation management in patients with atrial fibrillationJohn R Fanikos, Julie K Atay, Jean M Connors
Journal of Thrombosis and Haemostasis : JTH|March 27, 2023
Reclassifying hemophilia to include the definition of outcomes and phenotype as new targetsJecko Thachil, Jean M Connors, Johnny Mahlangu, et al.
Hematology. American Society of Hematology. Education Program|December 7, 2024
Troubleshooting heparin resistanceCheryl L Maier, Jean M Connors, Jerrold H Levy
Journal of Thrombosis and Haemostasis : JTH|October 11, 2024
Hematological causes of acute ischemic stroke in younger individualsGavin O'Toole, Dawn Swan, Jean M Connors, et al.
JAMA Network Open|August 6, 2021
Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic AlterationsOrly Leiva, Olesya Baker, Andrew Jenkins, et al.
Haematologica|October 15, 2020
The variable manifestations of disease in pyruvate kinase deficiency and their managementHanny Al-Samkari, Eduard J Van Beers, Kevin H M Kuo, et al.
American Journal of Hematology|May 7, 2024
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiencyKevin H M Kuo, Rachael F Grace, Eduard J van Beers, et al.
Pageof 34